News
The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.
The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...
ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.
Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.
BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...
A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
A Karolinska Institutet-led study has demonstrated that the use of an AI tool can enhance skin cancer diagnosis.
MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.
Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.
Carmat has filed for insolvency and requested that the Versailles Economic Affairs Court place it in a receivership.
Despite the threat of a 200% tariff, most pharma stocks remained stable. US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results